GSK-207040

Study Sponsor: GSK

Study Title

An open label, randomised, parallel group clinical study to evaluate the effect of the Connected Inhaler System (CIS) on adherence to Relvar/Breo ELLIPTA therapy, in asthmatic subjects with poor control

Medicine or Vaccine (generic name)

fluticasone furoate/vilanterol

Sponsor Identification Number

207040

Trial Registry Identification Number(#'s)

NCT03380429 2017-002266-45

Medical Condition

Asthma

Phase

Phase 4

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=207040

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT03380429

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=/2017-002266-45

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

An annotated case report form is not available for this study. A blank case report form will be provided. This study is available in CDISC format.

Date Added to this Site

February 2021